Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
|Articles|January 21, 2022
Daily OTC Pearl: Exederm
Author(s)Saro Arakelians, PharmD
Exederm treats itching, inflammation, redness, and rash associated with eczema and dermatitis.
Advertisement
Indication: Exederm is a flare control cream used for eczema and dermatitis.
Insight:
- Exederm contains 1% hydrocortisone anti-itch cream.
- Inactive Ingredients: Capric triglyceride, caprylic, caprylyl glycol, ceteareth-20, chamomile recutita flower extract, citric acid, glycerin, glyceryl stearate, palmitic acid, petrolatum, phenoxyethanol, stearic acid, and purified water.
- Avoid contact with the eyes.
- Do not begin use of any other hydrocortisone product unless directed by a physician.
- Exederm can relieve itching, inflammation, redness, and rash.
- Ultra-sensitive formula for highly sensitive skin.
- Fast acting when applied correctly.
Sources:
Advertisement
Related to this article
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
Phase 3 TRIUMPH-2 data presented at EASD show HbA1c reductions up to 1.6%, with GI effects, hypotension, and dysesthesia as key counseling points.
In a FINE-HEART analysis, cancer history raised the risk of death and hospitalization but did not blunt finerenone's cardiovascular and kidney benefits.
Hemoglobin, platelets, bleeding, pericardial effusions, and intrapulmonary shunting top the monitoring list for patients with pulmonary arterial hypertension (PAH) starting with sotatercept, according to Vallerie McLaughlin, MD.
Marie-Claire Seeley, PhD, MNurs, RN, discusses standing tests, medication review, and what inflammatory findings may mean for future POTS treatment.
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tiratricol, First Treatment for MCT8 Deficiency
2
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
3
Retatrutide Cuts Weight Up to 18.8% in Adults With T2D, Obesity
4
Sotatercept in ERS PAH Guidelines: What Pharmacists Should Watch
5